Categories Cannabis, U.S. Markets News

Arcadia’s stock gains 28% on industrial hemp program license

Arcadia Biosciences Inc.’s (RKDA) shares were up 28% in premarket hours on Monday after the company received an industrial hemp pilot program license from Hawaii’s Department of Agriculture.

The license allows the company to cultivate industrial hemp in Hawaii for research purposes through its new unit, Arcadia Specialty Genomics. Arcadia will start planting on ten acres of leased land next month. Hawaii is the first state to commence this program, which will also allow the commercial sale of hemp products.

Arcadia Biosciences' stock jumps 28% on industrial hemp program license
(Image Courtesy: Rick Proctor/Unsplash)

Last week, Arcadia unveiled its new division, Arcadia Specialty Genomics, which will focus on improving the quality, yield and climate resiliency of cannabis. The company’s stock jumped 68% on the announcement.

Read: Arcadia Biosciences enters cannabis market, shares soar 68%

Matt Plavan, CFO of Arcadia Biosciences and President of Arcadia Specialty Genomics said, “Industrial hemp, along with all strains of cannabis, are decades behind other agricultural crops in terms of improved plant genetics. With the explosive market growth projected in the industrial hemp and derivative markets, growers will need the very best hemp strains to meet demand, minimize waste, and ensure consistent quality. As the only company working in the cannabis industry with proven track record of improving plants and commercializing food ingredients from agricultural products using non-GM techniques, we’re ideally positioned to help hemp growers and end-users benefit from better hemp strains.”

The marijuana sector has been seeing rapid growth over the past couple of years. According to market research firm, Brightfield Group, cannabis sales are projected to reach $22 billion by 2022.

 

We’re on Flipboard! Follow us to receive the latest stock market, earnings and financial news at your fingertips.

Most Popular

BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to

Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights

Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per

BA Earnings: Highlights of Boeing’s Q1 2024 financial results

The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top